Does niacin decrease cardiovascular morbidity and mortality in CVD patients?

dc.contributor.author	Lazzopina, Peter	eng
dc.contributor.author	Mounsey, Anne	eng
dc.contributor.author	Handler, Lara	eng
dc.date.issued	2018	eng
dc.description.abstract	Q: Does niacin decrease cardiovascular morbidity and mortality in CVD patients? A: No. Niacin doesn't reduce cardio- vascular disease (CVD) morbidity or mortality in patients with established disease (strength of recommendation [SOR]: A, meta-analyses of randomized controlled trials [RCTs] and subsequent large RCTs). Niacin may be considered as mono-therapy for patients intolerant of statins (SOR: B, one well-done RCT).	eng
dc.description.statementofresponsibility	Authors: Peter Lazzopina, MD; Anne Mounsey, MD University of North Carolina Family Medicine Residency, Chapel Hill; Lara Handler, MSLS University of North Carolina, Chapel Hill	eng
dc.identifier.uri	https://hdl.handle.net/10355/63340	eng
dc.language	English	eng
dc.publisher	Family Physicians Inquiries Network	eng
dc.relation.ispartofcollection	Clinical Inquiries, 2018 (MU)	eng
dc.relation.ispartofcommunity	University of Missouri--Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network	eng
dc.relation.ispartofseries	Journal of family practice, 67, no. 05 (May 2018): 314-316.	eng
dc.rights	OpenAccess.	eng
dc.rights.license	This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.	eng
dc.title	Does niacin decrease cardiovascular morbidity and mortality in CVD patients?	eng
dc.type	Article	eng